Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Revance Therapeutics Inc RVNC

Revance Therapeutics, Inc. is a biotechnology company focused on developing and commercializing aesthetic and therapeutic offerings. The Company's portfolio includes DAXXIFY (DaxibotulinumtoxinA-lanm) for injection and the RHA Collection of dermal fillers in the United States. It has also partnered with Viatris to develop a biosimilar to onabotulinumtoxinA for injection and Fosun to... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:RVNC)

No current opinion is available.

Bullboard Posts (NDAQ:RVNC)

Neutral Recommendation Issued On RVNC By Piper Sandler

NEWS: $RVNC Neutral Recommendation Issued On RVNC By Piper Sandler2024-08-12 16:15:02 ET Piper Sandler analyst issues NEUTRAL...
whytestocks - August 12, 2024

RVNC Alert: Monsey Firm of Wohl & Fruchter Investigating Fai

JUST IN: $RVNC RVNC Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Revance Therapeutics to Crown...
whytestocks - August 12, 2024

Revance Announces Pricing of $100.0 Million Public Offering

Just In: $RVNC Revance Announces Pricing of $100.0 Million Public Offering of Common StockRevance Therapeutics, Inc. (Nasdaq: RVNC...
whytestocks - March 4, 2024